Department of Otolaryngology - Head & Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Scripps Clinic, La Jolla.
Otol Neurotol. 2020 Dec;41(10):e1328-e1332. doi: 10.1097/MAO.0000000000002883.
Retrospective analysis.
Tertiary referral center.
Adult (≥18 yr) patients underwent translabyrinthine or retrosigmoid VS resection by a single neurotologist and single neurosurgeon between February 2008 and December 2017.
Long-term FN outcomes (≥12 mo) according to House-Brackmann (HB) grade.
During the study period, 350 patients underwent VS resection, of whom 290 met inclusion criteria. Translabyrinthine surgery was performed in 54% (n = 158) and retrosigmoid in 45% (n = 131). One patient underwent a combined approach. Among patients who underwent retrosigmoid approach, none had a tumor more than 30 mm. Gross total resection was achieved in 98% (n = 283). Long-term HB1-2 function was achieved in 90% (n = 261). On univariate analysis, tumor size (per cm increase), history of preoperative radiation, and worse HB score at discharge predicted worse FN function. Multivariate analysis showed that tumor size (per cm increase) and history of radiation were independent predictors of FN function. For patients with tumors less than 30 mm, multivariate analysis of tumor size and surgical approach was performed; tumor size remained predictive of worse FN function (odds ratio [OR] 2.362, p = 0.0035), whereas surgical approach was not significantly predictive (p = 0.7569).
Tumor size and history of radiation predict long-term FN function after VS resection. When accounting for tumor size, the translabyrinthine and retrosigmoid approaches yield equivalent FN results.
1)描述听神经瘤(VS)显微切除后面神经(FN)结局与肿瘤大小的关系。2)描述手术入路、术前放疗和术后早期 FN 功能对面神经长期预后的影响。
回顾性分析。
三级转诊中心。
2008 年 2 月至 2017 年 12 月期间,由一位神经耳科医师和一位神经外科医师对符合条件的成年(≥18 岁)患者行迷路或乙状窦后 VS 切除术。
根据 House-Brackmann(HB)分级评估长期 FN 预后(≥12 个月)。
研究期间,共 350 例患者行 VS 切除术,其中 290 例符合纳入标准。54%(n=158)的患者行迷路入路,45%(n=131)的患者行乙状窦后入路。1 例患者行联合入路。行乙状窦后入路的患者中,无一例肿瘤直径大于 30mm。98%(n=283)的患者达到大体全切除。90%(n=261)的患者达到 HB1-2 级功能。单因素分析显示,肿瘤大小(每增加 1cm)、术前放疗史和出院时 HB 评分更差与 FN 功能更差相关。多因素分析显示,肿瘤大小(每增加 1cm)和放疗史是 FN 功能的独立预测因素。对于肿瘤直径小于 30mm 的患者,对肿瘤大小和手术入路进行多因素分析;肿瘤大小仍然是 FN 功能更差的预测因素(比值比[OR]2.362,p=0.0035),而手术入路不是显著预测因素(p=0.7569)。
肿瘤大小和放疗史预测 VS 切除后面神经功能的长期预后。当考虑到肿瘤大小时,迷路入路和乙状窦后入路的 FN 结果相当。